157 related articles for article (PubMed ID: 38773471)
1. Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation.
Zheng M; Wu L; Xiao R; Cai J; Chen W; Shen S
BMC Cancer; 2024 May; 24(1):619. PubMed ID: 38773471
[TBL] [Abstract][Full Text] [Related]
2. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation.
Wang Q; Wu L; Cao R; Gao J; Chai D; Qin Y; Ma L; Wu S; Tao Y; Ma J; Wang ZW
Oncogene; 2022 Oct; 41(43):4795-4807. PubMed ID: 36127399
[TBL] [Abstract][Full Text] [Related]
3. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation.
Wu L; Yu K; Chen K; Zhu X; Yang Z; Wang Q; Gao J; Wang Y; Cao T; Xu H; Pan X; Wang L; Xia J; Li Y; Wang ZP; Ma J
Cell Death Dis; 2022 Mar; 13(3):231. PubMed ID: 35279684
[TBL] [Abstract][Full Text] [Related]
4. Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation.
Lin XT; Yu HQ; Fang L; Tan Y; Liu ZY; Wu D; Zhang J; Xiong HJ; Xie CM
Elife; 2021 Nov; 10():. PubMed ID: 34779401
[TBL] [Abstract][Full Text] [Related]
5. Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.
Chen X; Sahasrabuddhe AA; Szankasi P; Chung F; Basrur V; Rangnekar VM; Pagano M; Lim MS; Elenitoba-Johnson KS
Cell Death Differ; 2014 Oct; 21(10):1535-45. PubMed ID: 24992930
[TBL] [Abstract][Full Text] [Related]
6. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer.
Han X; Li Q; Liu C; Wang C; Li Y
J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849
[TBL] [Abstract][Full Text] [Related]
7. Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.
Wang K; Qu X; Liu S; Yang X; Bie F; Wang Y; Huang C; Du J
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1509-1521. PubMed ID: 29728763
[TBL] [Abstract][Full Text] [Related]
8. CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma.
Cao T; Cui Y; Wang Y; Wu L; Yu K; Chen K; Xia J; Li Y; Wang ZP; Ma J
Apoptosis; 2022 Dec; 27(11-12):979-991. PubMed ID: 36038736
[TBL] [Abstract][Full Text] [Related]
9. Fbxo45-mediated NP-STEP
Wang Q; Xu C; Cai R; An W; Yuan H; Xu M
Mol Oncol; 2022 Aug; 16(16):3017-3033. PubMed ID: 35838331
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
11. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract][Full Text] [Related]
12. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
Zeng F; You S; Dai X
Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase RBX1 drives the metastasis of triple negative breast cancer through a FBXO45-TWIST1-dependent degradation mechanism.
Shao J; Feng Q; Jiang W; Yang Y; Liu Z; Li L; Yang W; Zou Y
Aging (Albany NY); 2022 Jul; 14(13):5493-5510. PubMed ID: 35802537
[TBL] [Abstract][Full Text] [Related]
14. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
15. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73.
Peschiaroli A; Scialpi F; Bernassola F; Pagano M; Melino G
Oncogene; 2009 Sep; 28(35):3157-66. PubMed ID: 19581926
[TBL] [Abstract][Full Text] [Related]
16. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
17. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
Tuluhong D; Gao H; Li X; Wang L; Zhu Y; Xu C; Wang J; Li H; Li Q; Wang S
Exp Cell Res; 2023 Dec; 433(1):113805. PubMed ID: 37839786
[TBL] [Abstract][Full Text] [Related]
18. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
19. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
[TBL] [Abstract][Full Text] [Related]
20. FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Ji J; Liu W; Liu B
Cell Death Dis; 2021 Jul; 12(8):758. PubMed ID: 34333526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
